GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Access Bio Inc (XKRX:950130) » Definitions » Cash From Discontinued Investing Activities

Access Bio (XKRX:950130) Cash From Discontinued Investing Activities : ₩0 Mil (TTM As of Jun. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Access Bio Cash From Discontinued Investing Activities?

Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Access Bio's cash from discontinued investing activities for the three months ended in Jun. 2024 was ₩0 Mil. It means Access Bio received ₩0 Mil from discontinued investing activities. Access Bio's cash from discontinued investing activities for the trailing twelve months (TTM) ended in Jun. 2024 was ₩0 Mil.

Access Bio Cash From Discontinued Investing Activities Historical Data

The historical data trend for Access Bio's Cash From Discontinued Investing Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Access Bio Cash From Discontinued Investing Activities Chart

Access Bio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash From Discontinued Investing Activities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Access Bio Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cash From Discontinued Investing Activities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Access Bio Cash From Discontinued Investing Activities Calculation

Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Cash From Discontinued Investing Activities for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Access Bio Cash From Discontinued Investing Activities Related Terms

Thank you for viewing the detailed overview of Access Bio's Cash From Discontinued Investing Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

Access Bio Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Access Bio Inc (XKRX:950130) » Definitions » Cash From Discontinued Investing Activities
Comparable Companies
XKRX:461030 XKRX:084650 XKRX:038290 XKRX:217330 XKRX:180400 XKRX:253840 XKRX:384470 XKRX:950200 XKRX:109820 XKRX:153710 TMO DHR XSWX:LONN IQV A IDXX MTD ICLR ILMN WAT
Traded in Other Exchanges
N/A
Address
65 Clyde Road, Suite A, Somerset, NJ, USA, 08873
Website
http://www.accessbio.net
Access Bio Inc is a United States based bio company engaged in the research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. The products are for the prevention and early diagnosis of infectious diseases. The company's core in vitro-diagnostic technology includes immunochemical, biochemical and molecular products. The company offers products for Rapid Diagnostic Tests including CareStart G6PD RDT, CareStart Malaria, CareStart Dengue Combo, and CareStart Scrub Typhus IgM; Biosensors product includes CareStart G6PD Biosensor, and Molecular Diagnostics products include CareStart HPV and CareStart CAH.

Access Bio Headlines

No Headlines